SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vineet Laboratories - Quaterly Results

13 Aug 2024 Evaluate
The sales moved down -36.41% to Rs. 238.62 millions for the June 2024 quarter as compared to Rs. 375.23 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2024 is Rs. -21.32 millions as compared to Net Loss of Rs. -12.50 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -4.23% as compared to 2.86% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 238.62 375.23 -36.41 238.62 375.23 -36.41 1505.91 2122.93 -29.06
Other Income 3.73 0.26 1334.62 3.73 0.26 1334.62 4.63 1.23 276.42
PBIDT -4.23 2.86 -247.90 -4.23 2.86 -247.90 76.63 77.82 -1.53
Interest 11.37 9.59 18.56 11.37 9.59 18.56 47.81 33.80 41.45
PBDT -15.60 -6.73 131.80 -15.60 -6.73 131.80 28.82 44.02 -34.53
Depreciation 6.09 6.09 0.00 6.09 6.09 0.00 25.19 23.73 6.15
PBT -21.69 -12.82 69.19 -21.69 -12.82 69.19 3.63 20.29 -82.11
TAX -0.37 -0.32 15.63 -0.37 -0.32 15.63 -6.64 7.77 -185.46
Deferred Tax -0.37 -0.32 15.63 -0.37 -0.32 15.63 -5.99 2.17 -376.04
PAT -21.32 -12.50 70.56 -21.32 -12.50 70.56 10.27 12.52 -17.97
Equity 92.19 92.19 0.00 92.19 92.19 0.00 92.19 92.19 0.00
PBIDTM(%) -1.77 0.76 -332.58 -1.77 0.76 -332.58 5.09 3.67 38.82

Vineet Laboratories Share Price

39.50 -0.19 (-0.48%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×